Evidence map›Paper›PMID 29037660›Full record

ArticleBehavioural brain research2018

NMDA receptor blockade specifically impedes the acquisition of incentive salience attribution.

Jonathan J Chow, Joshua S Beckmann

Abstract read
In one paragraph

Article in Behavioural brain research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jonathan J ChowDepartment of Psychology, University of Kentucky, 741 S. Limestone, Lexington, KY, 40536 USA. Electronic address: jonathan.chow@uky.edu.
Joshua S BeckmannDepartment of Psychology, University of Kentucky, 741 S. Limestone, Lexington, KY, 40536 USA. Electronic address: joshua.beckmann@uky.edu.

Funding

Training in Drug Abuse Related Research.T32DA016176 · NIDA · UNIVERSITY OF KENTUCKY · PI DWOSKIN, LINDA P · 2004 to 2020
$4.0M
Tonic and Phasic Glutamate Release in Incentive Salience and Cocaine ReinforcemenR00DA033373 · NIDA · UNIVERSITY OF KENTUCKY · PI BECKMANN, JOSHUA · 2014 to 2016
$741k
Tonic and Phasic Glutamate Release in Incentive Salience and Cocaine ReinforcemenK99DA033373 · NIDA · UNIVERSITY OF KENTUCKY · PI BECKMANN, JOSHUA · 2012 to 2013
$263k
NIDA NIH HHS K99 DA033373NIDA NIH HHS R00 DA033373NIDA NIH HHS T32 DA016176
6 · The paper itself

Abstract

Glutamatergic signaling plays an important role in learning and memory. Using Pavlovian conditioned approach procedures, the mechanisms that drive stimulus-reward learning and memory have been investigated. However, there are instances where reward-predictive stimuli can function beyond being solely predictive and can be attributed with "motivational value" or incentive salience. Using a Pavlovian conditioned approach procedure consisting of two different but equally predictive stimuli (lever vs. tone) we investigated the role NMDA receptor function has in the attribution of incentive salience. The results revealed that the administration of MK-801, an NMDA receptor antagonist, during acquisition of Pavlovian conditioned approach promoted goal-tracking to a lever stimulus, while control animals learned to sign-track. Moreover, within the same animals, the use of a tone stimulus elicited goal-tracking responses that were unaffected by MK-801 pretreatments. Furthermore, a lever CS that elicited sign-tracking served as a more robust conditioned reinforcer than a tone CS that elicited goal-tracking or a lever CS that elicited goal-tracking via MK-801 pretreatments. Collectively, these results demonstrate that NMDA receptor antagonism can alter the stimulus-reward relationship learned and prevent the attribution of incentive salience, rather than impede general learning.

Indexed as

RewardAnimalsConditioning, OperantCuesDizocilpine MaleateExcitatory Amino Acid AntagonistsMaleRatsRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateDizocilpine MaleateExcitatory Amino Acid AntagonistsReceptors, N-Methyl-D-AspartateGlutamateGoal-trackingIncentive salienceMK-801Sign-tracking

Identifiers

PMID29037660
PMCPMC5681870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.